The Japanese authorities intend to destroy a large volume of previously purchased COVID-19 drugs totaling about 300 billion yen (1.93 billion), Report informs citing Kyodo.

These are drugs Xocova manufactured by Shionogi, Lagevrio manufactured by Merck, as well as Paxlovid tablets from Pfizer.

These drugs would be enough for 5.6 million people. Most of the drugs remained unused and must be disposed of.